The ability to manipulate living organisms is at the heart of a range of emerging technologies that serve to address important
and current problems in environment, energy, and health. However, with all its complexity and interconnectivity, biology has
for many years been recalcitrant to engineering manipulations. The recent advances in synthesis, analysis, and modeling methods
have finally provided the tools necessary to manipulate living systems in meaningful ways and have led to the coining of a
field named synthetic biology. The scope of synthetic biology is as complicated as life itself—encompassing many branches
of science and across many scales of application. New DNA synthesis and assembly techniques have made routine customization
of very large DNA molecules. This in turn has allowed the incorporation of multiple genes and pathways. By coupling these
with techniques that allow for the modeling and design of protein functions, scientists have now gained the tools to create
completely novel biological machineries. Even the ultimate biological machinery—a self‐replicating organism—is being pursued
at this moment. The aim of this article is to dissect and organize these various components of synthetic biology into a coherent
picture. WIREs Syst Biol Med 2011 3 7–20 DOI: 10.1002/wsbm.104
This WIREs title offers downloadable PowerPoint presentations of figures for non-profit,
educational use, provided the content is not modified and full credit is given to the author
Synthesis of large DNA molecules in yeast. (a) Yeast homologous recombination mechanism. DNA fragments sharing an overlap region at 3′‐ and 5′‐ends with the neighboring DNA fragments can be assembled into a single larger DNA molecule. (b) Construction of a synthetic M. genitalium genome. Twenty‐five different overlapping DNA segments (blue arrows, 17–35 kb each) composing the genome were co‐transformed into yeast followed by assembly of the entire genome in a single step.
Analog‐to‐digital converter. (a) In this example system, the two toggle switches are initially ‘off’, i.e., repressor 2 and repressor 4 are expressed. Separately in a sensor array, repressor 1 has an input dependent promoter with a low input threshold. When input concentration rises above its threshold, repressor 1 is expressed, switching the state of toggle switch 1 to ‘on’. Using another input dependent promoter that has a higher threshold, switch 2 is toggled ‘on’ at a higher input concentration. (b) The corresponding digital response of the example gene switches.
Artemisinin biosynthetic pathway. The mevalonate‐based FPP biosynthetic pathway has been assembled from S. cerevisiae (HMG‐CoA synthase, hmgS; N‐terminally truncated HMG‐CoA reductase, thmgR; mevalonate kinase, mk; phosphomevalonate kinase, pmk; and mevalonate diphosphate decarboxylase, mpd) and E. coli (acetoacetyl‐CoA synthase, atoB; IPP isomerase, idi; and FPP synthase, ispA), and expressed in E. coli. The pathway is assembled in two operons, one is responsible for converting acetyl‐CoA to mevalonate, and the other is responsible for converting mevalonate to FPP. Further introduction of amorphadiene synthase (ads), oxidase (p450), and redox partner (cpr) allows the strain to convert FPP to artemisinic acid which can be chemically converted to artemisinin..
A synthetic predator–prey ecosystem. The system consists of two engineered bacterial populations that control each other's survival and death. CcdB is a cytotoxic protein that kills the cell and CcdA is its antidote. In the predator, CcdB is constitutively expressed, and will die off without an external signal. The antidote CcdA is expressed only when the predator receives signaling molecules (3OC6HSL) from the prey. At high enough prey concentration, the predator will survive. However, the prey also receives signaling molecules (3OC12HSL) from the predator. In the prey, CcdB is expressed in response to the predator signal. Therefore, in high enough predator concentration, the prey will die.
earned her Ph.D. at the University of Pennsylvania and has been at Duke University since 1993. She earned her endowed professorship, the James B. Duke Professor of Cell Biology, for the meaningful discoveries she has made since her postdoctoral work in genetics at the National Institute for Medical Research in London. The broad goal of the research in Dr. Capel’s laboratory is to characterize the cellular and molecular basis of morphogenesis – how the body forms. She uses gonadal (gender/sex) development in the mouse as her model system and investigates a gene she helped discover, Sry, the male sex determining gene. Gonad development is unique in that a single rudimentary tissue can be induced to form one of two different organs, an ovary or testis, and she is learning all she can about this central mystery of biology.